methylcobalamin

Acute functional B12 deficiency, leading to megaloblastic anemia, myelosuppression, and neurological damage (e.g., subacute combined degeneration of the spinal cord), especially in patients with pre-existing marginal B12 status.

Avoid prolonged exposure to nitrous oxide in patients with B12 deficiency or at risk. Pre-treat with B12 if prolonged exposure is anticipated in at-risk patients. Monitor neurological status.

Impaired therapeutic response to B12 supplementation in patients with megaloblastic anemia.

Avoid concurrent use if possible in patients being treated for megaloblastic anemia. If unavoidable, monitor hematological parameters closely and consider alternative antibiotics.

Decreased serum vitamin B12 levels, potential for B12 deficiency with long-term use.

Monitor B12 levels in patients on long-term colchicine. Supplement B12 if deficiency is detected.

Reduced efficacy of oral methylcobalamin, potential for worsening B12 deficiency

Monitor vitamin B12 levels. Consider parenteral methylcobalamin or higher oral doses if deficiency persists. Separate administration times if possible, though acid suppression is prolonged.

Decreased serum vitamin B12 levels, potential for B12 deficiency symptoms (e.g., neuropathy, anemia) with long-term use.

Monitor B12 levels in patients on long-term metformin. Supplement B12 (methylcobalamin) if deficiency is detected or suspected, especially in patients with risk factors for neuropathy.

Decreased serum vitamin B12 levels, potential for B12 deficiency.

Monitor B12 levels if neomycin is used for prolonged periods. Supplement B12 if deficiency is detected.

Potential for reduced efficacy of methylcobalamin, especially in patients with combined B12 and folate deficiencies

Monitor vitamin B12 and folate levels in patients on long-term phenobarbital. Supplementation with both B12 and folate may be necessary.

Potential for reduced efficacy of methylcobalamin, especially in patients with combined B12 and folate deficiencies

Monitor vitamin B12 and folate levels in patients on long-term phenytoin. Supplementation with both B12 and folate may be necessary.

Potential for reduced efficacy of methylcobalamin, especially in patients with combined B12 and folate deficiencies

Monitor vitamin B12 and folate levels in patients on long-term primidone. Supplementation with both B12 and folate may be necessary.

Reduced efficacy of oral methylcobalamin, potential for worsening B12 deficiency

Monitor vitamin B12 levels. Consider parenteral methylcobalamin or higher oral doses if deficiency persists. Separate administration times if possible, though acid suppression is prolonged.

Decreased serum vitamin B12 levels, potential for B12 deficiency with long-term use.

Monitor B12 levels in patients on long-term PPIs. Consider B12 supplementation if deficiency is detected or suspected.

Mild decrease in serum B12 levels; clinical deficiency is rare unless other risk factors are present.

Generally no specific management required unless other risk factors for B12 deficiency are present. Consider monitoring B12 levels in symptomatic patients.